Emergency medicine Australasia : EMA
-
Emerg Med Australas · Feb 2024
Changing culture: An intervention to improve blood culture quality in the emergency department.
Blood cultures (BCs) remain a key investigation in ED patients at risk of bacteraemia. The aim of this study was to assess the effect of a multi-modal, nursing-led intervention to improve the quality of BCs in the ED, in terms of single culture, underfilling and contamination rates. ⋯ Significant improvements in BC quality are possible with nursing-based interventions in the ED.
-
Emerg Med Australas · Feb 2024
Evaluation of stable chest pain following emergency department presentation: Impact of first-line cardiac computed tomography diagnostic strategy in an Australian setting.
International guidelines provide increasing support for computed tomography coronary angiography (CTCA) in investigating chest pain. A pathway utilising CTCA first-line for outpatient stable chest pain evaluation was implemented in an Australian ED. ⋯ The pathway increased CTCA utilisation and reduced downstream investigations. CTCA was associated with medication changes and improved ICA efficiency.
-
Emerg Med Australas · Feb 2024
End-of-life care: A retrospective cohort study of older people who died within 48 hours of presentation to the emergency department.
To describe the characteristics of, and care provided to, older people who died within 48 h of ED presentation. ⋯ Identification of patients at end-of-life (EoL) is not always straightforward; consider recent reduction in independence and recent ED visits/hospital admissions. System-based strategies that span pre-hospital, ED and in-patient care are recommended to facilitate EoL pathway implementation and care continuity.
-
Emerg Med Australas · Feb 2024
Emergency department presentations for chest complaints after mRNA COVID-19 vaccinations in children and adolescents.
To investigate characteristics and management of children presenting with chest complaints to a tertiary paediatric ED post-mRNA COVID-19 vaccine. ⋯ There was a large number of possible mRNA COVID-19 vaccine-related chest complaints presenting to the ED. Few patients had abnormal troponins or myocarditis.